Amphastar Pharmaceuticals (AMPH) Inventory (2013 - 2026)

Amphastar Pharmaceuticals' Inventory history runs 14 years deep, the most recent figure standing at $170.2 million for Q1 2026.

• On a quarterly basis, Inventory fell 8.24% year-over-year to $170.2 million in Q1 2026; TTM through Mar 2026 was $170.2 million, a 8.24% decrease from a year earlier, with the FY2025 full-year figure at $176.9 million, up 15.06% from the prior year.
• Inventory retreated to $170.2 million in Q1 2026 per AMPH's latest filing, from $176.9 million in the prior quarter.
• Across five years, Inventory topped out at $191.7 million in Q2 2025 and bottomed at $95.1 million in Q1 2022.
• The 5-year median for Inventory is $115.5 million (2024), against an average of $132.8 million.
• Across the five-year window, Inventory surged 60.59% in 2025 and slipped 8.24% in 2026, its largest moves.
• Year by year, Inventory stood at $103.6 million in 2022, then gained by 2.17% to $105.8 million in 2023, then soared by 45.27% to $153.7 million in 2024, then increased by 15.06% to $176.9 million in 2025, then slipped by 3.79% to $170.2 million in 2026.
• Per Business Quant, the three latest AMPH Inventory figures stand at $170.2 million (Q1 2026), $176.9 million (Q4 2025), and $185.9 million (Q3 2025).